Press Release

Multi-omics Startup Pleno Inc. Announces $40 Million in Series A Funding Led by Deerfield Management with Participation by Foresite Capital

Immunitas Therapeutics to Present Preclinical Data on IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies

Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund

Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer

Multi-omics Startup Pleno Inc. Announces $15 Million in Pre-Series A Funding

ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO

Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners

Aspen Neuroscience Launches First Patient Screening Study for Planned Clinical Trial of Personalized Cell Replacement in Parkinson’s Disease

ProJenX Announces First Person Dosed in Phase 1 Study of Prosetin